20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T1537 | Rapamycin | Sirolimus,AY 22989,NSC-2260804 | Others , Endogenous Metabolite , Antibiotic , mTOR , Autophagy , Antifungal |
Rapamycin (AY 22989) is a natural product of macrolides, an mTOR inhibitor with specificity (HEK293 cells: IC50=0.1 nM). Rapamycin has immunosuppressive activity and induces autophagy. | |||
T38963 | Seco Rapamycin | Secorapamycin A | |
Seco Rapamycin, also known as Secorapamycin A, is a ring-opened derivative derived from Rapamycin. It has been observed that Seco-rapamycin does not impact the function of mTOR. | |||
T36314 | Wortmannin-Rapamycin Conjugate | ||
Phosphoinositide 3-kinase (PI3K) and mammalian target of rapamycin (mTOR) act synergistically in promoting cancer. Wortmannin is a potent inhibitor of PI3K enzymes, while rapamycin blocks mTOR Complex 1 TORC1. Wortmannin... | |||
T12691 | Rapamycin-d3 | AY-22989-d3,Sirolimus-d3 | Others |
Rapamycin-d3 is the deuterium labeled Rapamycin. Rapamycin is a potent and specific inhibitor of mTOR(IC50 of 0.1 nM in HEK293 cells). | |||
T10158 | 42-(2-Tetrazolyl)rapamycin | Others | |
42-(2-Tetrazolyl)rapamycin is a prodrug compound of a rapamycin analog. | |||
T19558 | Seco Rapamycin sodium salt | Secorapamycin A monosodium | Others |
Seco Rapamycin sodium salt is a ring-opened product of Rapamycin. | |||
T25882 | 7-O-Demethyl rapamycin | CJ 12263,CJ12263,7-O-Demethyl Rapammune,Novolimus (80%),7-O-Demethyl Cypher,Novolimus,CJ-12263 | |
Novolimus is a macrocyclic lactone with anti-proliferative properties. It has similar efficacy to currently available agents but requires a lower dose. | |||
T74014 | Seco Rapamycin ethyl ester | ||
Seco Rapamycin ethyl ester, an open-ring metabolite of the Rapamycin derivative, reportedly does not impact mTOR function [1]. | |||
T14033 | 3BDO | Apoptosis , mTOR , Autophagy | |
3BDO is an activator of mTOR. It can also inhibit autophagy.. | |||
T40351 | MHY-1685 | mTOR | |
MHY-1685 is a mammalian target of rapamycin (mTOR) inhibitor and a senescence inhibitor that can rejuvenate senile hCSCs by modulating autophagy. | |||
T6030 | XL388 | P450 , PI3K , mTOR | |
XL388 is a highly effective, specifc, ATP-competitive inhibitor of mTOR ( IC50: 9.9 nM), 1000-fold selectivity than the closely related PI3K kinases. | |||
T6045 | Torin 1 | DNA-PK , PI3K , mTOR , Autophagy | |
Torin 1 is an effective inhibitor of mTORC1/2 with (IC50: 2 nM/10 nM); has 1000-fold selectivity for mTOR than PI3K. | |||
T1859 | AZD-8055 | Apoptosis , mTOR , Autophagy | |
AZD8055 is an ATP-competitive mTOR inhibitor (IC50: 0.8 nM in MDA-MB-468 cells). It is ~1,000-fold selective for mTOR over all PI3K isoforms. | |||
T5472 | PQR620 | mTOR | |
PQR620 is a novel potent and selective, brain penetrant inhibitor of mTORC1/2. | |||
T2475 | KU-0063794 | mTOR | |
KU-0063794 is a potent and highly specific dual-mTOR inhibitor of mTORC1 and mTORC2. | |||
T3514 | CZ415 | mTOR | |
CZ415 is a potent and highly selective mTOR inhibitor. | |||
T12270 | NV-5138 | mTOR | |
NV-5138 is a selective and orally active activator of brain mTORC1, with antidepressant effects. | |||
T12123 | MTOR inhibitor-3 | mTOR | |
mTOR inhibitor-3 is a selective mTOR inhibitor (Ki= 1.5 nM). mTOR inhibitor-3 inhibits mTORC1 and mTORC2 in cellular and in vivo experiments. | |||
T5338 | MTOR inhibitor-1 | mTOR , Autophagy | |
C-4 is a potential ATP-competitive inhibitor of mTOR. C-4 could inhibit cell growth and proliferation. | |||
T6100 | Torin 2 | Apoptosis , ATM/ATR , DNA-PK , mTOR , Autophagy | |
Torin 2(IC50=0.25 nM), a specific and effective mTOR inhibitor, is the 800-fold greater specific activity for mTOR than PI3K and improves pharmacokinetic properties. The EC50 of Torin 2 for ATM/ATR/DNA-PK inhibition is 2... |